Northwest Investment Counselors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$103K Buy
+3,556
New +$104K 0.02% 184
2024
Q2
Sell
-3,194
Closed -$88.6K 404
2024
Q1
$88.6K Buy
+3,194
New +$88.6K 0.02% 190
2023
Q4
Sell
-7,356
Closed -$244K 418
2023
Q3
$244K Sell
7,356
-517
-7% -$18.3K 0.07% 141
2023
Q2
$289K Sell
7,873
-1,793
-19% -$69.8K 0.08% 136
2023
Q1
$394K Sell
9,666
-1,470
-13% -$63.5K 0.11% 125
2022
Q4
$571K Buy
11,136
+2,953
+36% +$142K 0.16% 106
2022
Q3
$358K Buy
8,183
+204
+3% +$9.91K 0.12% 124
2022
Q2
$418K Buy
7,979
+2
+0% +$102 0.13% 113
2022
Q1
$413K Sell
7,977
-45
-0.6% -$2.33K 0.11% 119
2021
Q4
$474K Buy
8,022
+140
+2% +$6.94K 0.12% 118
2021
Q3
$339K Buy
7,882
+2,323
+42% +$103K 0.09% 123
2021
Q2
$218K Hold
5,559
0.06% 136
2021
Q1
$201K Hold
5,559
0.06% 140
2020
Q4
$205K Buy
5,559
+1,459
+36% +$53.5K 0.06% 137
2020
Q3
$143K Buy
+4,100
New +$144K 0.05% 141
2019
Q4
Sell
-2,226
Closed -$76K 398
2019
Q3
$76K Buy
+2,226
New +$80.9K 0.03% 191
2017
Q4
Sell
-3,473
Closed -$118K 256
2017
Q3
$118K Buy
3,473
+708
+26% +$22.8K 0.05% 133
2017
Q2
$88K Buy
+2,765
New +$87.2K 0.04% 144

Other funds holding PFE

Northwest Investment Counselors's PFE Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in Pfizer (PFE) in Q3 2024: 3,556 shares worth $103K. The stake represents 0.02% of the portfolio and ranks #184 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in PFE as recently as Q1 2024.

Northwest Investment Counselors first reported a position in PFE in Q2 2017 and has held it in 18 quarters since. The position peaked at $571K in Q4 2022. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Northwest Investment Counselors held 3,556 shares of Pfizer worth $103K as of Q3 2024.
  • Pfizer was a new Northwest Investment Counselors position in Q3 2024.
  • Pfizer made up 0.02% of Northwest Investment Counselors's portfolio in Q3 2024, its #184 holding.
  • Northwest Investment Counselors first reported a position in Pfizer in Q2 2017 and has held it in 18 quarters since.
  • Northwest Investment Counselors's Pfizer position peaked at $571K in Q4 2022.
  • 2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.